Name: SRS19518627 - Non-tumor sample from CD3-positive PBMC of a human male participant in the dbGaP study "Phase 2 Study of Pembrolizumab in Combination with Gemcitabine and Cisplatin as Neoadjuvant Therapy"
Creator: Saket Lab
License: https://www.ncbi.nlm.nih.gov/home/about/policies/

SRS19518627 - Non-tumor sample from CD3-positive PBMC of a human male participant in the dbGaP study "Phase 2 Study of Pembrolizumab in Combination with Gemcitabine and Cisplatin as Neoadjuvant Therapy" | seqout